AzTrials
AzTrials

GlaucomaNCT00321386

Analysis of Clinical Profiles of Chinese Patients With Normal Tension Glaucoma

An observational study of Glaucoma, run by Chinese University of Hong Kong at 2 sites in Hong Kong.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To obtain demographic and baseline ophthalmic parameters (such as Intraocular Pressure profiles, disc morphological characteristics, central corneal thickness, peripapillary retinal nerve fibre layer thickness and its serial changes, visual field changes, severity of any medical associations-e.g. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Glaucoma
How many people
500 participants
Where
2 sitesHong Kong
Study dates
Dec 2003to Dec 2012
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients with Normal Tension Glaucoma recruited from a teritary University Eye Hospital setting.

Who may be able to join

  • All Chinese patients with age>18 years old with Normal Tension Glaucoma will be recruited

Who cannot join

  • Diseases that precluded accurate measurement of IOP, visual acuity, retinal nerve fiber layer thickness, and visual field tests.
  • Previous ocular surgery per se is not an exclusion criteria.

Trial locations and contacts

2 sites in 1 country.

LEUNG YL Dexter, MBChB, FRCS contact

852-27623000

dexleung@alumni.cuhk.net

Hong Kong2 sites, 2 recruiting
  • Hong Kong Eye Hospital

    Hong Kong

    LEUNG YL Dexter, MBChB, FRCS, 852-27623000, dexleung@alumni.cuhk.net

    THAM CY Clement, MA, MD, FRCS

    Recruiting
  • Prince of Wales Hospital

    Hong Kong

    Recruiting

Other trials in Hong Kong

About this study

Official title: Parameters for Disease Progression in Chinese Patients With Normal Tension Glaucoma

To obtain demographic and baseline ophthalmic parameters (such as Intraocular Pressure profiles, disc morphological characteristics, central corneal thickness, peripapillary retinal nerve fibre layer thickness and its serial changes, visual field changes, severity of any medical associations-e.g. hypertension, migraine, strokes, silent cerebral infarcts) with non-invasive measurements, in Chinese Patients with Normal Tension Glaucoma

Read the detailed description

This is a multi-centered non-interventional descriptive study. The Declaration of Helsinki is followed. All procedures will be conducted in accordance with the GCP guidelines.

About 100 Consecutive NTG glaucoma patients will be included in this study. NTG is defined as:

  1. Six median untreated intraocular pressure consistently less than 21 mm Hg, with no more than 1 reading = 23 mmHg or 24 mmHg, and with no single measurement greater than 24 mm Hg,
  2. Open drainage angles on gonioscopy,
  3. Typical optic disc damage with glaucomatous cupping and loss of neuroretinal rim,
  4. Absence of any secondary cause for a glaucomatous optic neuropathy (trauma, steroids, uveitis),
  5. Glaucomatous visual field defect compatible with glaucomatous optic neuropathy.

Age and sex-matched normal control subjects and age, sex, severity-matched POAG control subjects will be recruited.

Randomization not required as this will be a non-interventional descriptive study.

A complete baseline ophthalmic assessment will be performed with Snellen visual acuity (VA), Best-corrected VA, intraocular pressure (IOP) measurements, slit lamp examination, gonioscopy, disc assessment and dilated fundal examination.

These measurements were performed at recruitment and then at 3,6,9,12 months after the intervention. The details of some of these measurements were as follows.

All IOP was measured with Goldmann applanation tonometry. The median of 5 readings were taken. Gonioscopy was carried out first using a Goldmann 2-mirror gonioscope. The examination was carried out at the lowest level of illumination that permitted a view of the angle and at high magnification (×16 to ×25). A 1-mm light beam was reduced to a very narrow slit, and was offset horizontally for assessing superior and inferior angles and vertically for nasal and temporal angles. Care was taken to avoid light falling on the pupil during gonioscopy. Slight tilting to gain a view over the convexity of the iris was permitted, but further manipulation of the lens or redirection of gaze was avoided because of the possibility of exerting pressure on the cornea and artificially widening the angle. The drainage angle was graded according to Shaffer's convention in each quadrant. The average angle width was calculated by adding the Shaffer grade in each quadrant and dividing by 4. Indentation gonioscopy using a Posner lens was also used to detect PAS, and the number of clock hours of PAS was recorded. All gonioscopy was performed by a single investigator for standardization.

The vertical CDR was taken to be the longest vertical cup diameter divided by the longest vertical disc diameter. Estimates were made to the nearest 0.05. The vertical disc diameter was examined. All features of a glaucomatous optic neuropathy were noted.

All subjects underwent static automated white-on-white threshold perimetry (program 24- 2, SITA standard, model 750, Humphrey Instruments, Dublin, CA), and the first reliable VF was used in our analysis. The global indices mean deviation (MD), and pattern standard deviation (PSD) were documented for all cases. After finding the proportion of VF that is reliable, the VF was then scored using the tested scoring algorithm developed for the Advanced Glaucoma Intervention Study (AGIS).

Minimal criteria for glaucomatous VF defect were as follows: glaucoma hemifield test outside normal limits, pattern standard deviation with a P value of <5%, or a cluster of ≥3 points in the pattern deviation plot in a single hemifield (superior or inferior) with P value of <5%, one of which must have a P value of <1%. Any one of the preceding criteria, if repeatable, was considered sufficient evidence of a glaucomatous VF defect.

Subjects will be verified by diurnal tension curve, which was recorded no more than one year before inclusion in the present study.

Systemic haemodynamics Systolic, diastolic, and mean blood pressures (SBP, DBP, MAP) were measured on the upper arm by an automated oscillometric device. Pulse rate (PR) and blood oxygenation was automatically recorded from a finger pulse oximetric device (HP-CMS patient monitor, Hewlett Packard, Palo Alto, CA, USA).

Measurement of intraocular pressure (IOP) A Median of 3 readings for each subject with Goldmann applanation tonometer was used for each measurement of intraocular pressure.

Fundus Photography and Optical Coherence Tomography (OCT) A baseline fundus photo will be performed for all participants. A baseline OCT for retinal nerve fiber layer thickness and optic nerve head parameters will be determined. Serial changes of these parameters will be correlated to VF indices.

Dynamic Contour Tonometry (DCT) and Ocular Response Analyzer (ORA) will also be performed on these subjects.

A history of the following systemic conditions was recorded: systemic hypertension (HT), hypotension, ischemic heart disease (IHD), arrhythmia, diabetes mellitus (DM), hypercholesterolemia, cerebral vascular accidents (CVA), migraine, obstructive sleep apnea (OSA), sensorineural hearing loss and Raynaud's phenomenon. All diagnoses were obtained from the history and confirmed by the clinical management system of the Hong Kong Hospital Authority, which is a computerized database connecting all public hospitals and clinics in Hong Kong.

Systemic use of statins, beta-blockers, angiotensin-converting-enzyme-inhibitors (ACEI), calcium-channel-blockers, aspirin and diuretics was also noted.

Conditions
Glaucoma
Keywords
Glaucoma, Open Angle, Normal Tension
Medical subject headings
Glaucoma

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 May 2006 (estimated)
  2. Study startDec 2003
  3. Primary completionDec 2008
  4. Study completionDec 2012 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00321386
Sponsor's protocol ID
KC/KE 05-0169/ER-1
Other IDs
CRE-2005.434
Status last verified
Jun 2011
First submitted
1 May 2006
Last updated
28 Jun 2011
Results posted
No
Data monitoring committee
Yes

Publications

  • Drance S, Anderson DR, Schulzer M; Collaborative Normal-Tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 2001 Jun;131(6):699-708. doi: 10.1016/s0002-9394(01)00964-3.

    PubMed 11384564
  • Leung DY, Tham CC, Li FC, Kwong YY, Chi SC, Lam DS. Silent cerebral infarct and visual field progression in newly diagnosed normal-tension glaucoma: a cohort study. Ophthalmology. 2009 Jul;116(7):1250-6. doi: 10.1016/j.ophtha.2009.02.003. Epub 2009 May 30.

    PubMed 19481813
  • Leung DY, Li FC, Kwong YY, Tham CC, Chi SC, Lam DS. Simvastatin and disease stabilization in normal tension glaucoma: a cohort study. Ophthalmology. 2010 Mar;117(3):471-6. doi: 10.1016/j.ophtha.2009.08.016. Epub 2010 Jan 4.

    PubMed 20045568
  • Leung DY, Kwong YY, Li FC, Tham CC, Chi SC, Lam DS. Comparison of the clinical characteristics of normal tension glaucoma patients with pretreatment intraocular pressures in the high-teens and low-teens. Br J Ophthalmol. 2010 May;94(5):663-5. doi: 10.1136/bjo.2009.163014. No abstract available.

    PubMed 20447973
  • Leung DY, Iliev ME, Chan P, Baig N, Chi SC, Tham CC, Lam DS. Pressure-cornea-vascular index (PCVI) for predicting disease progression in normal tension glaucoma. Br J Ophthalmol. 2011 Aug;95(8):1106-10. doi: 10.1136/bjo.2009.175992. Epub 2010 Aug 7.

    PubMed 20693562

Questions about this trial

What is this clinical trial studying?

An observational study of Glaucoma, run by Chinese University of Hong Kong at 2 sites in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Jun 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact LEUNG YL Dexter, MBChB, FRCS (852-27623000, dexleung@alumni.cuhk.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00321386, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jun 2011; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in